Misoone (Misoprostol)

Misoprostol, the active ingredient in Misoone, is a prostaglandin analog presented as an oral dosage form for systemic use. It is employed to protect the gastric mucosa in patients taking NSAIDs and to induce uterine contraction for obstetric indications. The drug is classified as a gastroprotective agent and is prescribed under medical supervision.

GNH USA supplies Misoone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for global distribution.

Misoprostol, a prostaglandin E1 analogue, is used in several therapeutic areas that involve gastric mucosal protection or uterine smooth‑muscle activity.

- Prevention of NSAID‑induced gastric ulcers: reduces ulcer formation in patients receiving non‑steroidal anti‑inflammatory drugs. - Medical termination of pregnancy: induces uterine contraction and cervical ripening to facilitate termination. - Induction of labor: promotes cervical softening and uterine activity to initiate vaginal delivery. - Management of postpartum hemorrhage: stimulates uterine contraction to control bleeding after delivery.

Misoprostol may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Abdominal pain: cramp‑like discomfort in the stomach area. - Diarrhea: loose stools occurring shortly after dosing. - Nausea: feeling of queasiness or urge to vomit. - Fever: mild increase in body temperature.

Serious or Rare Side Effects: - Severe uterine bleeding: heavy vaginal hemorrhage requiring medical attention. - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Persistent vomiting: inability to retain oral intake leading to dehydration.

Before prescribing Misoone, clinicians should consider several safety precautions to minimize risk. - Assess renal function: adjust use in patients with severe renal impairment. - Avoid in pregnancy: contraindicated because of risk of fetal harm and uterine rupture. - Monitor uterine activity: watch for hyperstimulation during labor induction. - Review concomitant NSAID therapy: ensure appropriate gastroprotective measures are in place. - Store at ambient temperature: keep in the original packaging, protect from moisture and light.

Misoprostol can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Combined use with other prostaglandin analogs: may cause excessive uterine contraction. - Concurrent high‑dose NSAIDs: can diminish misoprostol’s gastroprotective effect. - Use with misoprostol‑containing abortifacients: additive uterine activity increases risk of complications.

Moderate Interactions (Monitor Closely): - Antacids: may alter absorption and reduce effectiveness. - Corticosteroids: increase risk of gastrointestinal ulceration despite misoprostol therapy. - Warfarin: potential for altered bleeding risk; monitor coagulation parameters.